The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization
Anne S. Lixenfeld, Inga Künsting, Emily L. Martin, Vera von Kopylow, Selina Lehrian, Hanna B. Lunding, Jana S. Buhre, Janna Quack, Moritz Steinhaus, Tobias Graf, View ORCID ProfileMarc Ehlers, Johann Rahmöller
doi: https://doi.org/10.1101/2021.03.10.21252001
Anne S. Lixenfeld
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Inga Künsting
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Emily L. Martin
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Vera von Kopylow
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Selina Lehrian
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Hanna B. Lunding
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Jana S. Buhre
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Janna Quack
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Moritz Steinhaus
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
2Department of Anesthesiology and Intensive Care, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Tobias Graf
3Medical Department 3, University Medical Center of Schleswig-Holstein, Lübeck, Germany
Marc Ehlers
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
4Airway Research Center North (ARCN), University of Lübeck, German Center for Lung Research (DZL), Lübeck, Germany
Johann Rahmöller
1Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
2Department of Anesthesiology and Intensive Care, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
Data Availability
Our ethics does not allow to share the data without signing an agreement. Parties interested can contact the corresponding author to obtain access to this data.
Posted March 12, 2021.
The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization
Anne S. Lixenfeld, Inga Künsting, Emily L. Martin, Vera von Kopylow, Selina Lehrian, Hanna B. Lunding, Jana S. Buhre, Janna Quack, Moritz Steinhaus, Tobias Graf, Marc Ehlers, Johann Rahmöller
medRxiv 2021.03.10.21252001; doi: https://doi.org/10.1101/2021.03.10.21252001
The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization
Anne S. Lixenfeld, Inga Künsting, Emily L. Martin, Vera von Kopylow, Selina Lehrian, Hanna B. Lunding, Jana S. Buhre, Janna Quack, Moritz Steinhaus, Tobias Graf, Marc Ehlers, Johann Rahmöller
medRxiv 2021.03.10.21252001; doi: https://doi.org/10.1101/2021.03.10.21252001
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4409)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2838)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)